UMC Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - UMediC Group Bhd - Alpha Spread
U

UMediC Group Bhd
KLSE:UMC

Watchlist Manager
UMediC Group Bhd
KLSE:UMC
Watchlist
Price: 0.61 MYR 1.67% Market Closed
Market Cap: 228.1m MYR
Have any thoughts about
UMediC Group Bhd?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

UMC Price Targets Summary
UMediC Group Bhd

Wall Street analysts forecast UMC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UMC is 0.97 MYR with a low forecast of 0.89 MYR and a high forecast of 1.07 MYR.

UMC Lowest Forecast
Wall Street Target
0.89 MYR
46% Upside
UMC Average Forecast
Wall Street Target
0.97 MYR
59% Upside
UMC Highest Forecast
Wall Street Target
1.07 MYR
76% Upside
Lowest
Price Target
0.89 MYR
46% Upside
Average
Price Target
0.97 MYR
59% Upside
Highest
Price Target
1.07 MYR
76% Upside
UMediC Group Bhd Competitors:
Price Targets
4164
CHC Healthcare Group
53% Upside
E
4104
Excelsior Medical Co Ltd
12% Downside
CAU
Cronos Australia Ltd
178% Upside
ILM1
Medios AG
91% Upside
4164
CHC Healthcare Group
53% Upside
E
4104
Excelsior Medical Co Ltd
12% Downside
CAU
Cronos Australia Ltd
178% Upside
ILM1
Medios AG
91% Upside
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
4% Upside
9729
Tokai Corp (Gifu)
19% Upside
E
EBO
EBOS Group Ltd
8% Upside
HSIC
Henry Schein Inc
3% Upside

Revenue
Forecast

Revenue Estimate
UMediC Group Bhd

For the last 3 years the compound annual growth rate for UMediC Group Bhd's revenue is 24%. The projected CAGR for the next 3 years is 23%.

24%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
UMediC Group Bhd

For the last 3 years the compound annual growth rate for UMediC Group Bhd's operating income is 56%. The projected CAGR for the next 3 years is 24%.

56%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
UMediC Group Bhd

For the last 3 years the compound annual growth rate for UMediC Group Bhd's net income is 62%. The projected CAGR for the next 3 years is 19%.

62%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
UMC intrinsic value, competitors valuation, and company profile.
DCF Valuation
UMC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UMC stock valuation using valuation multiples.
Wall Street Estimates
UMC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UMC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UMC's stock price target?
Price Target
0.97 MYR

According to Wall Street analysts, the average 1-year price target for UMC is 0.97 MYR with a low forecast of 0.89 MYR and a high forecast of 1.07 MYR.

What is UMediC Group Bhd's Revenue forecast?
Projected CAGR
23%

For the last 3 years the compound annual growth rate for UMediC Group Bhd's revenue is 24%. The projected CAGR for the next 3 years is 23%.

What is UMediC Group Bhd's Operating Income forecast?
Projected CAGR
24%

For the last 3 years the compound annual growth rate for UMediC Group Bhd's operating income is 56%. The projected CAGR for the next 3 years is 24%.

What is UMediC Group Bhd's Net Income forecast?
Projected CAGR
19%

For the last 3 years the compound annual growth rate for UMediC Group Bhd's net income is 62%. The projected CAGR for the next 3 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 179,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.